Skip to content
DraconiticResearch
Search Sources API
197,783 studies31 sourcesUpdated 42 min ago
Peer-reviewedCC BY-NC-NDJournal of the anus, rectum and colon

Risk Stratification Based on Endoscopic Ulcerative Findings in Patients with Endoscopic Non-Complete Response after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.

7 affiliations
  1. 1Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  2. 2Department of Gastroenterology and Hepatology, Mie University Hospital, Mie, Japan.
  3. 3Department of Colorectal Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  4. 4Department of Radiation Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  5. 5Department of Gastroenterological Chemotherapy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  6. 6Department of Gastroenterology, Kanagawa Cancer Center, Kanagawa, Japan.
  7. 7Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.

Abstract

Few studies have evaluated ulcerative findings after chemoradiotherapy (CRT) or total neoadjuvant therapy (TNT) for rectal cancer. This study aimed to evaluate risk stratification based on ulcerative findings and their association with pathological non-complete response (pNon-CR) in patients classified as endoscopic non-complete response (eNon-CR). Among patients with stage II/III rectal adenocarcinoma who underwent surgery after CRT or TNT between April 2018 and March 2025, those diagnosed with eNon-CR at the final preoperative endoscopy were included. The eNon-CR endoscopic findings were defined as the presence of definite neoplastic nodules, ulceration, poor wall distensibility, and neoplastic pits or tumor vessels under magnification. Ulcerative lesions without other tumor-related endoscopic findings, even under magnifying endoscopy, were defined as isolated ulcers and degree of depression (shallow/deep), and association with pNon-CR was analyzed. In total 154 patients were analyzed. Of these, 18 (11.7%) achieved pathological complete response. Isolated ulcers (n=22) had a positive predictive value (PPV) for pNon-CR of 63.6% (95% confidence interval [CI]: 40.7-82.8), whereas ulceration with neoplastic pits or tumor vessels identified by magnifying endoscopy (n=13) had a PPV of 84.6% (95% CI; 54.6-98.1). When isolated ulcers were subclassified, shallow ulcers (n=5) had a low PPV of 20.0% (95% CI: 5.0-71.6), whereas deep ulcers (n=17) had a PPV of 76.5% (95% CI: 50.1-93.2) (p = 0.039). In the endoscopic evaluation of ulcerative findings, magnifying endoscopy may be helpful for assessing eNon-CR. Subclassification of isolated ulcers may aid in the risk stratification of eNon-CR.

Related

  1. Adverse event risks and prognostic factors associated with endoscopic laryngopharyngeal surgery for superficial head and neck cancer after chemoradiotherapy
    Sakiko Naito, Hayato Yamaguchi, Masakatsu Fukuzawa +3
    International Journal of Clinical OncologyPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  2. Clinical, Endoscopic, and Histopathological Features Distinguishing Amebic Colitis from Ulcerative Colitis in a Male Cohort: A Single-Center Retrospective Study.
    Xinyu Li, Kunning Zhang, Jun Lu +4
    Infection and drug resistancePeer-reviewedCC BY-NCFull textInfectious diseaseEurope PMCPMC
  3. Pathological Response Depth and Pre-Treatment Risk Stratification After Neoadjuvant Chemoradiotherapy for Rectal Cancer.
    Tibiana Negru, Loredana Gabriela Stana, Livia Stanga +3
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textOncologyEurope PMCDOAJ
  4. Stratification of gastric cancer risk based on family history with cost-effectiveness of opportunistic endoscopic screening: a hospital-based cross-sectional study (SIGES)
    Zhuo-Yu Li, Wen Xiang, Yan Huang +1
    Frontiers in oncologyPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCCrossref
  5. Identification of NUDT6 and LINGO1 as candidate genes for nCRT-associated signatures to neoadjuvant chemoradiotherapy in rectal cancer patients
    Qian Wang, Guangpeng Shen, Juntao Wang +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
BibTeX
@article{kido2026risk,
  title = {{Risk Stratification Based on Endoscopic Ulcerative Findings in Patients with Endoscopic Non-Complete Response after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.}},
  author = {Koyo Kido and Akiko Chino and Takashi Akiyoshi and Junki Tokura and Keigo Suzuki and Mitsuaki Ishioka and Daisuke Ide and Senzo Taguchi and Hiroki Osumi and Eiji Shinozaki and Manabu Takamatsu and Shoichi Saito},
  journal = {Journal of the anus, rectum and colon},
  year = {2026},
  month = oct,
  doi = {10.23922/jarc.2026-021},
  url = {https://europepmc.org/article/MED/42952900},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Risk Stratification Based on Endoscopic Ulcerative Findings in Patients with Endoscopic Non-Complete Response after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
AU  - Koyo Kido
AU  - Akiko Chino
AU  - Takashi Akiyoshi
AU  - Junki Tokura
AU  - Keigo Suzuki
AU  - Mitsuaki Ishioka
AU  - Daisuke Ide
AU  - Senzo Taguchi
AU  - Hiroki Osumi
AU  - Eiji Shinozaki
AU  - Manabu Takamatsu
AU  - Shoichi Saito
PY  - 2026
DA  - 2026/10/25
JO  - Journal of the anus, rectum and colon
DO  - 10.23922/jarc.2026-021
UR  - https://europepmc.org/article/MED/42952900
AB  - Few studies have evaluated ulcerative findings after chemoradiotherapy (CRT) or total neoadjuvant therapy (TNT) for rectal cancer. This study aimed to evaluate risk stratification based on ulcerative findings and their association with pathological non-complete response (pNon-CR) in patients classified as endoscopic non-complete response (eNon-CR). Among patients with stage II/III rectal adenocarcinoma who underwent surgery after CRT or TNT between April 2018 and March 2025, those diagnosed with eNon-CR at the final preoperative endoscopy were included. The eNon-CR endoscopic findings were defined as the presence of definite neoplastic nodules, ulceration, poor wall distensibility, and neoplastic pits or tumor vessels under magnification. Ulcerative lesions without other tumor-related endoscopic findings, even under magnifying endoscopy, were defined as isolated ulcers and degree of depression (shallow/deep), and association with pNon-CR was analyzed. In total 154 patients were analyzed. Of these, 18 (11.7%) achieved pathological complete response. Isolated ulcers (n=22) had a positive predictive value (PPV) for pNon-CR of 63.6% (95% confidence interval [CI]: 40.7-82.8), whereas ulceration with neoplastic pits or tumor vessels identified by magnifying endoscopy (n=13) had a PPV of 84.6% (95% CI; 54.6-98.1). When isolated ulcers were subclassified, shallow ulcers (n=5) had a low PPV of 20.0% (95% CI: 5.0-71.6), whereas deep ulcers (n=17) had a PPV of 76.5% (95% CI: 50.1-93.2) (p = 0.039). In the endoscopic evaluation of ulcerative findings, magnifying endoscopy may be helpful for assessing eNon-CR. Subclassification of isolated ulcers may aid in the risk stratification of eNon-CR.
SN  - 2432-3853
ER  -